Aquestive Therapeutics, Inc.

Contributing Author

Recent Articles by Aquestive Therapeutics, Inc.

Jun-25	Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit AQST GlobeNewswire
Jun-16	Aquestive Therapeutics Announces FDA Acceptance of New Drug Application and PDUFA Date for Anaphylm for the Treatment of Severe Allergic Reactions AQST GlobeNewswire
May-12	Aquestive Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update AQST GlobeNewswire
May-05	Aquestive Therapeutics to Participate in Citizens Life Sciences Conference AQST GlobeNewswire